http://www.citeulike.org/group/5070/article/6250832
Posted via email from nocx
Beginner's Ride
http://www.citeulike.org/group/5070/article/6250832
Posted via email from nocx
Posted via email from nocx
http://www.landesbioscience.com/journals/epigenetics/article/11161
Posted via email from nocx
Posted via email from nocx
http://www.tuxradar.com/content/ubuntu-netbook-remix-vs-moblin
Posted via email from nocx
Leonard C. Schalkwyk and colleagues from IOP:
Posted via email from nocx
Posted via email from nocx
Am J Psychiatry. 2010 Feb;167(2):190-197. Epub 2009 Dec 15.
Brent D, Melhem N, Ferrell R, Emslie G, Wagner KD, Ryan N, Vitiello B, Birmaher B, Mayes T, Zelazny J, Onorato M, Devlin B,Clarke G, Debar L, Keller M.
Dr. Birmaher has participated in forums sponsored by Abcomm, Forest Laboratories, Jazz Pharmaceuticals, Shire Pharmaceuticals, and Solvay Pharmaceuticals and has received royalties from Random House and Lippincott Williams & Wilkins. Dr. Emslie has received research support from Biobehavioral Diagnostics, Forest Laboratories, Shire, and Somerset and is a consultant for Biobehavioral Diagnostics, Eli Lilly, Forest Laboratories, Pfizer, Shire, Validus Pharmaceuticals, and Wyeth. Dr. Keller has received research support or speakers honoraria from, served as a consultant to, or served on advisory boards for Abbott Laboratories, Bristol-Myers Squibb, CENEREX, Cephalon, Cyberonics, Cypress Bioscience, Forest Laboratories, Janssen, JDS, Medtronic, Neuronetics, Novartis, Organon, Pfizer, Roche, Solvay, and Wyeth. All other authors report no financial relationships with commercial interests.
Objective The authors sought to assess the relationship between candidate genes and two clinical outcomes, namely, symptomatic improvement and the occurrence of suicidal events, in a sample of treatment-resistant depressed adolescents. Method A subsample of depressed adolescents participating in the Treatment of SSRI-Resistant Depression in Adolescents (TORDIA) trial, 155 of whom were of European origin, were genotyped with respect to 21 polymorphisms on 12 genes that have a reported association with depression, treatment response, or suicidal events. Participants had not responded to a previous adequate trial with an antidepressant and were randomized to receive either another selective serotonin reuptake inhibitor or venlafaxine, with or without cognitive-behavioral therapy (CBT). Single-nucleotide polymorphism (SNP) analyses were conducted using PLINK with permutation procedures. Results No relationship was observed between any polymorphism and response to treatment. The FKBP5 (which codes for a protein causing subsensitivity of the glucocorticoid receptor) rs1360780TT and rs3800373GG genotypes were associated with suicidal events (N=18), even after controlling for treatment effects and relevant covariates. These two SNPs were in significant linkage disequilibrium (r=0.91). Conclusions The FKBP5 genotypes associated with suicidal events in this study have been reported by others to cause the greatest degree of glucocorticoid receptor subsensitivity. These results are consistent with those of other studies linking alterations in the hypothalamic-pituitary-adrenal axis with suicidal behavior. The small number of events and lack of a placebo condition make these results preliminary. Replication with a larger sample and a placebo condition is needed to assess whether these events are related to treatment.
Posted via email from nocx
BMC Neurosci. 2010 Jan 14;11(1):4. [Epub ahead of print]
Tognoli C, Rossi F, Di Cola F, Baj G, Tongiorgi E, Terova G, Saroglia M, Bernardini G, Gornati R.
ABSTRACT: BACKGROUND: Stress involves alterations of brain functioning that may precipitate to mood disorders. The neurotrophin Brain Derived Neurotrophic Factor (BDNF) has recently been involved in stress-induced adaptation. BDNF is a key regulator of neuronal plasticity and adaptive processes. Regulation of BDNF is complex and may reflect not only stress-specific mechanisms but also hormonal and emotional responses. For this reason we used, as an animal model of stress, a fish whose brain organization is very similar to that of higher vertebrates, but is generally considered free of emotional reactions. Results: We provide a comprehensive characterization of BDNF gene in the Dicentrarchus labrax and its transcriptional, translational and post-translational regulation following acute stress. While total BDNF mRNA levels are unchanged, BDNF transcripts 1c and 1d resulted down regulated after acute stress. Acute stress induces also a significant increase in proBDNF levels and reduction in mature BDNF suggesting altered regulation of proBDNF proteolytic processing. Notably, we provide here the first evidence that fishes possess a simplified proteolytic regulation of BDNF since the pro28Kda form, generated by the SKI-1 protease in mammals, is absent in fishes because the cleavage site has first emerged in reptilians. Finally, we show that the proBDNF/totBDNF ratio is a highly predictive novel quantitative biomarker to detect stress in fishes with sensitivity=100%, specificity=87%, and Negative Predictive Value=100%. Conclusion: The high predictivity of proBDNF/totBDNF ratio for stress in lower vertebrates indicates that processing of BDNF is a central mechanism in adaptation to stress and predicts that a similar regulation of pro/mature BDNF has likely been conserved throughout evolution of vertebrates from fish to man.
Posted via email from nocx
Posted via email from nocx
Posted via email from nocx
On February 10 (12:00 am), the American Psychiatric Association (APA) will release the proposed draft diagnostic criteria forDSM
The proposed diagnostic criteria will be available on the Website www.dsm5.org, for public comment until April 20, 2010. APA is inviting health professionals, consumers of mental health services, and family members to visit the site to review and comment on the draft criteria.
Posted via email from nocx
Prolonged psychosocial stress is a condition assessed through self-reports. Here we aimed to identify biochemical markers for screening and early intervention in women.
Plasma concentrations of interleukin (IL) 1-α, IL1-β, IL-2, IL-4, IL-6, IL-8, IL-10, interferon-γ (INF-γ), tumor necrosis factor-α (TNF-α), monocyte chemotactic protein-1 (MCP-1), epidermal growth factor (EGF), vascular endothelial growth factor (VEGF), thyroid stimulating hormone (TSH), total tri-iodothyronine (TT3), total thyroxine (TT4), prolactin, and testosterone were measured in: 195 women on long-term sick-leave for a stress-related affective disorder, 45 women at risk for professional burnout, and 84 healthy women.
We found significantly increased levels of MCP-1, VEGF and EGF in women exposed to prolonged psychosocial stress. Statistical analysis indicates that they independently associate with a significant risk for being classified as ill.
MCP-1, EGF, and VEGF are potential markers for screening and early intervention in women under prolonged psychosocial stress. "
http://www.plosone.org/article/info:doi/10.1371/journal.pone.0003590
Posted via email from nocx
http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(10)60175-7/fulltext
Posted via email from nocx
http://archpsyc.ama-assn.org/cgi/content/abstract/67/2/146
Posted via email from nocx